Vergent Bioscience, Inc. — Form D/A

Vergent Bioscience, Inc. of MINNEAPOLIS, MN, a company, filed a Form D amendment with the SEC on 2025-02-18. The offering totals $5.0M, of which $3.8M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (26)

Showing 25 of 26 people.

NameRoleLocation
Samuel Dean BanksDirectorMinneapolis, MN
Ryan EgelandDirectorMaple Grove, MN
Jeff JulkowskiDirectorMinneapolis, MN
Douglas KohrsDirectorDALLAS, TX
John SantiniDirectorMinneapolis, MN
Anita WatkinsDirectorMinneapolis, MN
Raymond WongDirectorHong Kong, K3
John SantiniExecutive OfficerMinneapolis, MN
Jeffrey YureckoExecutive OfficerMinneapolis, MN
Bobby T HelmedagDirectorMinneapolis, MN
Jeffrey T YureckoExecutive OfficerMinneapolis, MN
Anita T WatkinsDirectorMinneapolis, MN
John T Santini, Jr.DirectorMinneapolis, MN
John T Santini, Jr.Executive OfficerMinneapolis, MN
Raymond T WongDirectorMinneapolis, MN
Douglas T KohrsDirectorMinneapolis, MN
Anita WilsonDirectorMinneapolis, MN
Samuel BanksDirectorToronto, A6
Margo ShoupDirectorMINNEAPOLIS, MN
Jeffrey JulkowskiDirectorMINNEAPOLIS, MN
Jeffrey JulkowskiPromoterMINNEAPOLIS, MN
Raymond Dean WongDirectorMINNEAPOLIS, MN
Ryan Dean EgelandDirectorMINNEAPOLIS, MN
Samuel Dean BanksDirectorMINNEAPOLIS, MN
Douglas Dean KohrsDirectorMINNEAPOLIS, MN

Other filings by this issuer (7)

FiledFormOfferingSold
2025-10-20D$32.0M$18.7M
2025-02-18D$5.0M$3.8M
2022-10-04D$22.1M$21.5M
2021-11-22D$2.0M$1.2M
2020-09-23D/A$11.9M$11.9M
2019-02-22D/A$9.7M$9.7M
2018-06-01D$8.7M$8.7M

More